How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Top Cited Papers
- 31 August 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (40), 3297-3317
- https://doi.org/10.1093/eurheartj/ehz641
Abstract
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the ‘HFA–PEFF diagnostic algorithm’. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for HF symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor. Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. The second step (E: Echocardiography and Natriuretic Peptide Score) requires comprehensive echocardiography and is typically performed by a cardiologist. Measures include mitral annular early diastolic velocity (e′), left ventricular (LV) filling pressure estimated using E/e′, left atrial volume index, LV mass index, LV relative wall thickness, tricuspid regurgitation velocity, LV global longitudinal systolic strain, and serum natriuretic peptide levels. Major (2 points) and Minor (1 point) criteria were defined from these measures. A score ≥5 points implies definite HFpEF; ≤1 point makes HFpEF unlikely. An intermediate score (2–4 points) implies diagnostic uncertainty, in which case Step 3 (F1: Functional testing) is recommended with echocardiographic or invasive haemodynamic exercise stress tests. Step 4 (F2: Final aetiology) is recommended to establish a possible specific cause of HFpEF or alternative explanations. Further research is needed for a better classification of HFpEF.Keywords
Funding Information
- Heart Failure Association
This publication has 259 references indexed in Scilit:
- Mortality and Sudden Death in Pediatric Left Ventricular Noncompaction in a Tertiary Referral CenterCirculation, 2013
- Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection FractionThe American Journal of Cardiology, 2012
- Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance taggingJournal of Cardiovascular Magnetic Resonance, 2011
- Increased Left Ventricular Stiffness Impairs Exercise Capacity in Patients with Heart Failure Symptoms Despite Normal Left Ventricular Ejection FractionCardiology Research and Practice, 2011
- Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2010
- Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular DysfunctionCirculation: Heart Failure, 2010
- Paget’s disease of bone: a review of epidemiology, pathophysiology and managementTherapeutic Advances in Musculoskeletal Disease, 2009
- Invasive Hemodynamic Assessment in Heart FailureHeart Failure Clinics, 2009
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Community-Based StudyJournal of the American College of Cardiology, 2009
- Abnormal Left Ventricular Energy Metabolism in Obese Men With Preserved Systolic and Diastolic Functions Is Associated With Insulin ResistanceDiabetes Care, 2007